Abiomed Inc (ABMD)

325.98 -11.80  -3.49% NASDAQ Nov 26, 16:00 USD

Abiomed Cash from Investing (TTM):

-250.42M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 1992. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -250.42M
June 30, 2021 -346.16M
March 31, 2021 -223.34M
Dec. 31, 2020 -177.14M
Sept. 30, 2020 -168.76M
June 30, 2020 -65.76M
March 31, 2020 -125.46M
Dec. 31, 2019 -171.17M
Sept. 30, 2019 -139.58M
June 30, 2019 -197.16M
March 31, 2019 -116.46M
Dec. 31, 2018 -149.16M
Sept. 30, 2018 -135.05M
June 30, 2018 -128.79M
March 31, 2018 -180.76M
Dec. 31, 2017 -181.53M
Sept. 30, 2017 -158.92M
June 30, 2017 -118.21M
March 31, 2017 -126.33M
Dec. 31, 2016 -86.74M
Sept. 30, 2016 -84.00M
June 30, 2016 -88.78M
March 31, 2016 -57.71M
Dec. 31, 2015 -44.25M
Sept. 30, 2015 -36.61M
   
June 30, 2015 -54.95M
March 31, 2015 -49.86M
Dec. 31, 2014 -46.86M
Sept. 30, 2014 -27.16M
June 30, 2014 -12.33M
March 31, 2014 -22.27M
Dec. 31, 2013 -13.56M
Sept. 30, 2013 -5.477M
June 30, 2013 -2.907M
March 31, 2013 -10.26M
Dec. 31, 2012 -12.38M
Sept. 30, 2012 -30.22M
June 30, 2012 -22.98M
March 31, 2012 -17.48M
Dec. 31, 2011 -11.17M
Sept. 30, 2011 -7.853M
June 30, 2011 -5.774M
March 31, 2011 -2.352M
Dec. 31, 2010 -1.102M
Sept. 30, 2010 5.403M
June 30, 2010 6.627M
March 31, 2010 8.818M
Dec. 31, 2009 9.246M
Sept. 30, 2009 8.339M
June 30, 2009 -31.17M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Benchmarks

Masimo Corp -33.41M
Repligen Corp -317.18M
Abbott Laboratories -2.068B

Cash from Investing (TTM) Range, Past 5 Years

Minimum -346.16M Jun 2021
Maximum -65.76M Jun 2020
Average -162.34M

News

Insider Sell: Abiomed
MT Newswires 11/19 06:57 ET
Notable earnings before Thursday's open
SA Breaking News 10/27 10:40 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.